SENTENCE,SENTENCE_MASKED,ASSOCIATION_TYPE,ENTITY1_TEXT,ENTITY2_TEXT,label
Our work supported LRP5 genetic variants as possible susceptibility factors for osteoporosis and fractures in humans.,Our work supported @GENE$ genetic variants as possible susceptibility factors for @DISEASE$ and fractures in humans.,SA,LRP5,osteoporosis,True
"Especially, the SNP rs491347 and its strongly associated SNPs (e.g., rs1784235) could be important to human osteoporosis phenotypes.","Especially, the SNP @DISEASE$ and its strongly associated SNPs (e.g., rs1784235) could be important to human @DISEASE$ phenotypes.",SA,rs491347,osteoporosis,True
"Especially, the SNP rs491347 and its strongly associated SNPs (e.g., rs1784235) could be important to human osteoporosis phenotypes.","Especially, the SNP rs491347 and its strongly associated SNPs (e.g., @DISEASE$) could be important to human @DISEASE$ phenotypes.",SA,rs1784235,osteoporosis,True
The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.,The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling @GENE$ level in carriers of @DISEASE$.,FA,fetal haemoglobin,beta-thalassaemia,False
Fetal haemoglobin (HbF) level modifies the clinical severity of HBB disorders.,Fetal haemoglobin (@GENE$) level modifies the clinical severity of @DISEASE$.,PA,HbF,HBB disorders,True
Fetal haemoglobin (HbF) level modifies the clinical severity of HBB disorders.,@GENE$ (HbF) level modifies the clinical severity of @DISEASE$.,PA,Fetal haemoglobin,HBB disorders,True
The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.,The @GENE$ intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of @DISEASE$.,FA,HBS1L-MYB,beta-thalassaemia,False
The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.,The HBS1L-MYB intergenic region on chromosome @GENE$ is a quantitative trait locus controlling fetal haemoglobin level in carriers of @DISEASE$.,FA,6q23,beta-thalassaemia,False
"Functional studies to unravel the biological significance of this region in regulating HbF production is clearly indicated, which may lead to new strategies to modify the disease course of severe HBB disorders.","Functional studies to unravel the biological significance of this region in regulating @GENE$ production is clearly indicated, which may lead to new strategies to modify the disease course of severe @DISEASE$.",FA,HbF,HBB disorders,False
"IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis.","IL-1, IL-1R and @GENE$ in Iranian patients with @DISEASE$.",PA,TNFalpha gene polymorphisms,multiple sclerosis,True
"On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian multiple sclerosis patients.","On the other hand the frequency of @DISEASE$ genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian @DISEASE$ patients.",FA,IL-1alpha TT -889,multiple sclerosis,False
"On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian multiple sclerosis patients.","On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), @GENE$ (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian @DISEASE$ patients.",PA,TNFalpha G -308 allele,multiple sclerosis,True
"IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis.","@GENE$, IL-1R and TNFalpha gene polymorphisms in Iranian patients with @DISEASE$.",PA,IL-1,multiple sclerosis,True
Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.,Overall and relapse-free survival in @DISEASE$ and hypopharyngeal squamous cell carcinoma are associated with genotypes of @DISEASE$ gene.,PA,T393C polymorphism of the GNAS1,oropharyngeal,True
Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.,Overall and relapse-free survival in oropharyngeal and @DISEASE$ are associated with genotypes of @DISEASE$ gene.,PA,T393C polymorphism of the GNAS1,hypopharyngeal squamous cell carcinoma,True
The T393C SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and hypopharyngeal cancer.,The @DISEASE$ SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and @DISEASE$.,FA,T393C,hypopharyngeal cancer,False
The T393C SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and hypopharyngeal cancer.,The @DISEASE$ SNP could be considered as a genetic marker to predict the clinical course of patients suffering from @DISEASE$ and hypopharyngeal cancer.,PA,T393C,oropharyngeal,True
"The prognostic value of the T393C SNP was evaluated in an unselected series of patients treated with curative intent for oropharyngeal and hypopharyngeal squamous cell carcinomas, including all tumor stages with different therapeutic regimens.","The prognostic value of the @DISEASE$ SNP was evaluated in an unselected series of patients treated with curative intent for @DISEASE$ and hypopharyngeal squamous cell carcinomas, including all tumor stages with different therapeutic regimens.",FA,T393C,oropharyngeal,False
"However, the majority of colon cancer cells have deregulation of the Wnt/beta-catenin pathway.","However, the majority of @DISEASE$ cells have deregulation of the @GENE$/beta-catenin pathway.",FA,Wnt,colon cancer,False
Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krüppel-like factor 5.,Lysophosphatidic acid facilitates proliferation of @DISEASE$ cells via induction of @GENE$.,FA,Krüppel-like factor 5,colon cancer,False
A recent study showed that LPA-mediated proliferation of colon cancer cells requires activation of beta-catenin.,A recent study showed that LPA-mediated proliferation of @DISEASE$ cells requires activation of @GENE$.,PA,beta-catenin,colon cancer,True
"On multivariate analysis the CYP3A5 A6986G genotype *3/*3 (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for leukocytopenia (grade 3 or greater) throughout the period of chemotherapy.","On multivariate analysis the @GENE$ (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for @DISEASE$ (grade 3 or greater) throughout the period of chemotherapy.",PA,CYP3A5 A6986G genotype *3/*3,leukocytopenia,True
"The A6986G polymorphism of CYP3A5, which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of leukocytopenia induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.","The @GENE$, which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of @DISEASE$ induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.",PA,A6986G polymorphism of CYP3A5,leukocytopenia,True
XRCC1 genotyping might make tailor chemotherapy possible for gastric cancer patients treated with oxaliplatin-based chemotherapy.,@GENE$ genotyping might make tailor chemotherapy possible for @DISEASE$ patients treated with oxaliplatin-based chemotherapy.,SA,XRCC1,gastric cancer,True
Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population.,@GENE$ predicts overall survival of @DISEASE$ patients receiving oxaliplatin-based chemotherapy in Chinese population.,PA,Polymorphism of XRCC1,gastric cancer,True
"This study assessed associations between the CYP4F2 gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).","This study assessed associations between the @GENE$ gene and @DISEASE$ (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).",PA,CYP4F2,myocardial infarction,True
A haplotype of the CYP4F2 gene associated with myocardial infarction in Japanese men.,A haplotype of the @GENE$ gene associated with @DISEASE$ in Japanese men.,PA,CYP4F2,myocardial infarction,True
"For men, G allele frequency of rs2108622 and frequency of the T-C-G haplotype were significantly higher, and frequency of the T-C-A haplotype was significantly lower for MI patients than for controls (P=0.006, P=0.001 and P=0.002, respectively).","For men, G allele frequency of @DISEASE$ and frequency of the T-C-G haplotype were significantly higher, and frequency of the T-C-A haplotype was significantly lower for @DISEASE$ patients than for controls (P=0.006, P=0.001 and P=0.002, respectively).",PA,rs2108622,MI,True
"This study assessed associations between the CYP4F2 gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).","This study assessed associations between the @GENE$ gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 @DISEASE$ patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).",FA,CYP4F2,MI,False
"When stratified by ALDH2 Ex1+82A>G polymorphism, alcohol-related increases in stomach cancer risk were restricted to individuals with the AG/GG genotypes, with a more than 2-fold risk among daily drinkers (OR=2.63, 95% CI=1.00-6.88) and 3-fold risk (OR=3.66, 95% CI=1.19-11.24) among those with 40 or more drink-years.","When stratified by @GENE$ polymorphism, alcohol-related increases in @DISEASE$ risk were restricted to individuals with the AG/GG genotypes, with a more than 2-fold risk among daily drinkers (OR=2.63, 95% CI=1.00-6.88) and 3-fold risk (OR=3.66, 95% CI=1.19-11.24) among those with 40 or more drink-years.",PA,ALDH2 Ex1+82A>G,stomach cancer,True
The COL1A2 gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (IAs) in the Japanese population.,The @GENE$ gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (@DISEASE$) in the Japanese population.,PA,COL1A2,IAs,True
The COL1A2 gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (IAs) in the Japanese population.,The @GENE$ gene at 7q22.1 has been shown to be associated with familial @DISEASE$ (IAs) in the Japanese population.,PA,COL1A2,intracranial aneurysms,True
The rs42524 polymorphism of COL1A2 could be a genetic risk factor for sporadic IAs among individuals of Chinese Han ethnicity.,The @DISEASE$ polymorphism of COL1A2 could be a genetic risk factor for sporadic @DISEASE$ among individuals of Chinese Han ethnicity.,SA,rs42524,IAs,True
"In the present study, the authors investigated the correlation between the presence of the rs42524 polymorphism in COL1A2 and the occurrence of sporadic IAs in Chinese patients.","In the present study, the authors investigated the correlation between the presence of the rs42524 polymorphism in @GENE$ and the occurrence of sporadic @DISEASE$ in Chinese patients.",FA,COL1A2,IAs,True
This study is the first to confirm the association between COL1A2 and IAs.,This study is the first to confirm the association between @GENE$ and @DISEASE$.,PA,COL1A2,IAs,True
The rs42524 polymorphism of COL1A2 could be a genetic risk factor for sporadic IAs among individuals of Chinese Han ethnicity.,The rs42524 polymorphism of @GENE$ could be a genetic risk factor for sporadic @DISEASE$ among individuals of Chinese Han ethnicity.,FA,COL1A2,IAs,True
"Surprisingly, the 602S allele is associated with a decreased incidence of leprosy, suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.","Surprisingly, the 602S allele is associated with a decreased incidence of @DISEASE$, suggesting that Mycobacterium leprae subverts the @GENE$ system as a mechanism of immune evasion.",FA,TLR,leprosy,True
Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy.,Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of @GENE$ but protects against @DISEASE$.,PA,TLR1,leprosy,False
"Surprisingly, the 602S allele is associated with a decreased incidence of leprosy, suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.","Surprisingly, the @DISEASE$ allele is associated with a decreased incidence of @DISEASE$, suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.",PA,602S,leprosy,False
These results suggest that combination of HDACi with adenoviral TRAIL gene therapy may be a new therapeutic approach for the treatment of prostate cancer that warrants further investigation.,These results suggest that combination of HDACi with adenoviral @GENE$ gene therapy may be a new therapeutic approach for the treatment of @DISEASE$ that warrants further investigation.,PA,TRAIL,prostate cancer,False
Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis.,Allelic and non-allelic heterogeneities in @DISEASE$ revealed by @GENE$ mutational analysis.,PA,ALDH7A1,pyridoxine dependent seizures,True
"Recently, mutations have been identified in the ALDH7A1 gene in Caucasian families with PDS.","Recently, mutations have been identified in the @GENE$ gene in Caucasian families with @DISEASE$.",FA,ALDH7A1,PDS,False
Cytochrome P450 1A1 is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma (HCC).,@GENE$ is a major enzyme in the bioactivation of exogenous procarcinogens of @DISEASE$ (HCC).,PA,Cytochrome P450 1A1,hepatocellular carcinoma,True
"However, the contribution of common genetic variants in CYP1A1 to the HCC risk in Chinese populations has not been thoroughly investigated.","However, the contribution of common genetic variants in @GENE$ to the @DISEASE$ risk in Chinese populations has not been thoroughly investigated.",SA,CYP1A1,HCC,True
Cytochrome P450 1A1 is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma (HCC).,@GENE$ is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma (@DISEASE$).,PA,Cytochrome P450 1A1,HCC,True
"Interestingly, the diplotype TTAC/CCAG also conferred an increased risk of HCC (OR 1.76, 95% CI 1.22-2.54, P=0.003).","Interestingly, the diplotype @DISEASE$ also conferred an increased risk of @DISEASE$ (OR 1.76, 95% CI 1.22-2.54, P=0.003).",PA,TTAC/CCAG,HCC,True
"To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of HCC (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.","To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and @DISEASE$ variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of @DISEASE$ (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.",PA,rs2198843,HCC,True
"To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of HCC (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.","To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of @DISEASE$ (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of @DISEASE$ variant.",PA,rs4886605,HCC,True
"Compared to the most common CYP1A1 haplotype CCAG, the haplotype TTGC conferred an increased risk of HCC (OR 1.26, 95% CI 1.04-1.52).","Compared to the most common @GENE$ haplotype CCAG, the haplotype TTGC conferred an increased risk of @DISEASE$ (OR 1.26, 95% CI 1.04-1.52).",FA,CYP1A1,HCC,False
"In this study, we examined the association between HCC and four selected tagging single nucleotide polymorphisms (SNPs) of CYP1A1, and the risk of CYP1A1 haplotypes/diplotypes in 1006 pathologically confirmed HCC patients and 1015 cancer-free controls, from a Han Chinese population.","In this study, we examined the association between HCC and four selected tagging single nucleotide polymorphisms (SNPs) of CYP1A1, and the risk of @GENE$ haplotypes/diplotypes in 1006 pathologically confirmed @DISEASE$ patients and 1015 cancer-free controls, from a Han Chinese population.",FA,CYP1A1,HCC,False
"Our results suggested that common genetic variants in CYP1A1 may modulate the risk of developing HCC in the study population, particularly in non-smokers.","Our results suggested that common genetic variants in @GENE$ may modulate the risk of developing @DISEASE$ in the study population, particularly in non-smokers.",SA,CYP1A1,HCC,True
Amyloid beta protein (Abeta) levels are elevated in the brain of Alzheimer's disease patients.,@GENE$ (Abeta) levels are elevated in the brain of @DISEASE$ patients.,PA,Amyloid beta protein,Alzheimer's disease,True
Amyloid beta protein (Abeta) levels are elevated in the brain of Alzheimer's disease patients.,Amyloid beta protein (@GENE$) levels are elevated in the brain of @DISEASE$ patients.,PA,Abeta,Alzheimer's disease,True
Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.,Anti-@GENE$ antibody passage across the blood-brain barrier in the SAMP8 mouse model of @DISEASE$: an age-related selective uptake with reversal of learning impairment.,FA,amyloid beta protein,Alzheimer's disease,False
"The results of a phase I clinical trial of the topoisomerase I (Topo I) poison CPT-11 followed by the cyclin-dependent kinase inhibitor flavopiridol in patients with advanced solid tumors indicate that patients whose tumors were wild-type, but not mutant, for p53 obtained the most clinical benefit from this combination therapy.","The results of a phase I clinical trial of the topoisomerase I (Topo I) poison CPT-11 followed by the cyclin-dependent kinase inhibitor flavopiridol in patients with advanced @DISEASE$ indicate that patients whose tumors were wild-type, but not mutant, for @GENE$ obtained the most clinical benefit from this combination therapy.",PA,p53,solid tumors,True
"To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity.","To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (@GENE$ in the etiopathogenesis of inflammatory bowel diseases (@DISEASE$), that may enhance susceptibility and/or disease severity.",FA,TNF)-alpha,IBD,False
"To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity.","To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (@GENE$ in the etiopathogenesis of @DISEASE$ (IBD), that may enhance susceptibility and/or disease severity.",FA,TNF)-alpha,inflammatory bowel diseases,False
"The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).","The @GENE$ in women and T in men at SNP +372 T/C was found to increase @DISEASE$ susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).",PA,TIMP-1 genotype TT,CD,True
"The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).","The @GENE$ in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of @DISEASE$ during follow-up (41.4% vs 68.3%, P = 0.025).",PA,TIMP-1 genotype TT,fistulae,True
"The 5T5T genotype at MMP-3 SNP -1613 5T/6T increased the chance of stenotic complications in CD during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).","The @DISEASE$ increased the chance of stenotic complications in @DISEASE$ during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).",PA,5T5T genotype at MMP-3 SNP -1613 5T/6T,CD,True
"Allelic composition at the examined SNPs in genes coding for TIMP-1 and MMP-3 affect CD susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.","Allelic composition at the examined SNPs in genes coding for @GENE$ and MMP-3 affect @DISEASE$ susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.",PA,TIMP-1,CD,True
"Allelic composition at the examined SNPs in genes coding for TIMP-1 and MMP-3 affect CD susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.","Allelic composition at the examined SNPs in genes coding for TIMP-1 and @GENE$ affect @DISEASE$ susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.",PA,MMP-3,CD,True
"To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity.","To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, @GENE$ (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (@DISEASE$), that may enhance susceptibility and/or disease severity.",FA,tissue inhibitors of metalloproteinases,IBD,False
"To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity.","To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, @GENE$ (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of @DISEASE$ (IBD), that may enhance susceptibility and/or disease severity.",FA,tissue inhibitors of metalloproteinases,inflammatory bowel diseases,True
"To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity.","To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and @GENE$ (TNF)-alpha in the etiopathogenesis of @DISEASE$ (IBD), that may enhance susceptibility and/or disease severity.",PA,tumor necrosis factor,inflammatory bowel diseases,True
"To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity.","To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and @GENE$ (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (@DISEASE$), that may enhance susceptibility and/or disease severity.",FA,tumor necrosis factor,IBD,True
"The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).","The TIMP-1 genotype TT in women and T in men at @DISEASE$ was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of @DISEASE$ during follow-up (41.4% vs 68.3%, P = 0.025).",FA,SNP +372 T/C,fistulae,True
"The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).","The TIMP-1 genotype TT in women and T in men at @DISEASE$ was found to increase @DISEASE$ susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).",PA,SNP +372 T/C,CD,True
"The 5T5T genotype at MMP-3 SNP -1613 5T/6T increased the chance of stenotic complications in CD during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).","The 5T5T genotype at @GENE$ SNP -1613 5T/6T increased the chance of stenotic complications in @DISEASE$ during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).",FA,MMP-3,CD,True
Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.,Ala394Thr polymorphism in the clock gene @GENE$: a circadian modifier for the risk of @DISEASE$.,PA,NPAS2,non-Hodgkin's lymphoma,True
Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.,@DISEASE$ polymorphism in the clock gene NPAS2: a circadian modifier for the risk of @DISEASE$.,FA,Ala394Thr,non-Hodgkin's lymphoma,True
STEC strains carrying stx2 were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or bloody diarrhea than those carrying stx2vha.,STEC strains carrying @GENE$ were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (@DISEASE$) or bloody diarrhea than those carrying stx2vha.,PA,stx2,HUS,True
STEC strains carrying stx2 were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or bloody diarrhea than those carrying stx2vha.,STEC strains carrying @GENE$ were more frequently associated with clinical manifestations of @DISEASE$ (HUS) or bloody diarrhea than those carrying stx2vha.,PA,stx2,hemolytic-uremic syndrome,True
STEC strains carrying stx2 were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or bloody diarrhea than those carrying stx2vha.,STEC strains carrying @GENE$ were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or @DISEASE$ than those carrying stx2vha.,PA,stx2,bloody diarrhea,True
"We conclude that stx genotype is one of the important factors of clinical outcome of STEC O157 infection and that pathogenicity for humans was higher in the stx2 genotype strains than in the stx2vha genotype strains, as reported previously by other researchers.","We conclude that stx genotype is one of the important factors of clinical outcome of @DISEASE$ and that pathogenicity for humans was higher in the @GENE$ genotype strains than in the stx2vha genotype strains, as reported previously by other researchers.",PA,stx2,STEC O157 infection,False
Subsequent analysis of individual SNPs in strong linkage disequilibrium with the ME2 gene revealed one SNP and one haplotype associated with the phenotype of psychosis in the CVCR sample.,Subsequent analysis of individual SNPs in strong linkage disequilibrium with the @GENE$ gene revealed one SNP and one haplotype associated with the phenotype of @DISEASE$ in the CVCR sample.,PA,ME2,psychosis,False
"ME2 interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.","@GENE$ interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and @DISEASE$, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.",PA,ME2,bipolar disorder,False
"ME2 interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.","@GENE$ interacts directly with the malate shuttle system, which has been shown to be altered in @DISEASE$ and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.",PA,ME2,schizophrenia,False
"The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder.","The present study suggests that genetic variation in or near the @GENE$ gene is associated with both @DISEASE$ and manic disorders, including schizophrenia and bipolar disorder.",PA,ME2,psychotic,False
"The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder.","The present study suggests that genetic variation in or near the @GENE$ gene is associated with both psychotic and @DISEASE$, including schizophrenia and bipolar disorder.",PA,ME2,manic disorders,True
"The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder.","The present study suggests that genetic variation in or near the @GENE$ gene is associated with both psychotic and manic disorders, including @DISEASE$ and bipolar disorder.",PA,ME2,schizophrenia,True
"The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder.","The present study suggests that genetic variation in or near the @GENE$ gene is associated with both psychotic and manic disorders, including schizophrenia and @DISEASE$.",PA,ME2,bipolar disorder,True
Genetic alterations within the p53 gene have been shown to have a direct correlation with cancer development and have been shown to occur in nearly 50% of all cancers.,Genetic alterations within the @GENE$ gene have been shown to have a direct correlation with cancer development and have been shown to occur in nearly 50% of all @DISEASE$.,PA,p53,cancers,True
This review discusses the role of p53 from normal function and its dysfunction in pre-cancerous lesions and non-melanoma skin cancers.,This review discusses the role of @GENE$ from normal function and its dysfunction in pre-cancerous lesions and @DISEASE$.,PA,p53,non-melanoma skin cancers,True
We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on CRP levels in chronic kidney disease (CKD) patients before and after a successful kidney transplantation.,We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on @GENE$ levels in chronic kidney disease (@DISEASE$) patients before and after a successful kidney transplantation.,PA,CRP,CKD,True
We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on CRP levels in chronic kidney disease (CKD) patients before and after a successful kidney transplantation.,We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on @GENE$ levels in @DISEASE$ (CKD) patients before and after a successful kidney transplantation.,PA,CRP,chronic kidney disease,True
The study investigated the possible association of NRG3 gene and schizophrenia in a Han Chinese population.,The study investigated the possible association of @GENE$ gene and @DISEASE$ in a Han Chinese population.,SA,NRG3,schizophrenia,True
"In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected schizophrenia offspring were observed.","In the haplotype-transmission disequilibrium test (TDT) for allelic combination of @DISEASE$, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected @DISEASE$ offspring were observed.",PA,rs1937970-rs677221,schizophrenia,True
"In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for schizophrenia (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).","In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with @DISEASE$ being the risk allele for @DISEASE$ (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).",PA,rs677221-C,schizophrenia,True
"In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for schizophrenia (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).","In case-control samples, two SNPs (@DISEASE$ and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for @DISEASE$ (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).",PA,rs1937970,schizophrenia,True
The result supports that the NRG3 gene is a susceptibility gene for schizophrenia.,The result supports that the @GENE$ gene is a susceptibility gene for @DISEASE$.,PA,NRG3,schizophrenia,True
Haplotypes GC constructed by the two SNPs was also significantly associated with schizophrenia (permutation p value = .0047).,@DISEASE$ constructed by the two SNPs was also significantly associated with @DISEASE$ (permutation p value = .0047).,PA,Haplotypes GC,schizophrenia,True
"In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected schizophrenia offspring were observed.","In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for @DISEASE$ (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected @DISEASE$ offspring were observed.",PA,haplotype AG,schizophrenia,True
"In the independent trio samples, rs1937970-A and rs677221-G consistently showed significant under-transmission to schizophrenic offspring (unadjusted p = .003 and p = .004, respectively).","In the independent trio samples, @DISEASE$ and rs677221-G consistently showed significant under-transmission to @DISEASE$ offspring (unadjusted p = .003 and p = .004, respectively).",PA,rs1937970-A,schizophrenic,True
"In the independent trio samples, rs1937970-A and rs677221-G consistently showed significant under-transmission to schizophrenic offspring (unadjusted p = .003 and p = .004, respectively).","In the independent trio samples, rs1937970-A and @DISEASE$ consistently showed significant under-transmission to @DISEASE$ offspring (unadjusted p = .003 and p = .004, respectively).",PA,rs677221-G,schizophrenic,True
"In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected schizophrenia offspring were observed.","In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for @DISEASE$ (uncorrected p = .004) to the affected @DISEASE$ offspring were observed.",PA,haplotype GC,schizophrenia,True
Neuregulin 3 genetic variations and susceptibility to schizophrenia in a Chinese population.,@GENE$ genetic variations and susceptibility to @DISEASE$ in a Chinese population.,PA,Neuregulin 3,schizophrenia,True
"In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for schizophrenia (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).","In case-control samples, two SNPs (rs1937970 and @DISEASE$) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for @DISEASE$ (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).",PA,rs677221,schizophrenia,True
These results suggest that the NLRP3 region is also implicated in the susceptibility of more common inflammatory diseases such as Crohn's disease.,These results suggest that the @GENE$ region is also implicated in the susceptibility of more common inflammatory diseases such as @DISEASE$.,SA,NLRP3,Crohn's disease,True
"We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of NLRP3 (previously known as CIAS1 and NALP3) that are associated with Crohn's disease.","We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of @GENE$ (previously known as CIAS1 and NALP3) that are associated with @DISEASE$.",PA,NLRP3,Crohn's disease,True
"We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of NLRP3 (previously known as CIAS1 and NALP3) that are associated with Crohn's disease.","We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of NLRP3 (previously known as CIAS1 and @GENE$) that are associated with @DISEASE$.",PA,NALP3,Crohn's disease,True
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility.,Common variants in the @GENE$ region contribute to @DISEASE$ susceptibility.,PA,NLRP3,Crohn's disease,True
"Therefore, the mutations of the MDR1 gene are thought to be related with the pathogenesis of inflammatory bowel disease.","Therefore, the mutations of the @GENE$ gene are thought to be related with the pathogenesis of @DISEASE$.",SA,MDR1,inflammatory bowel disease,True
"In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis.","In this study, the G2677T/A polymorphism observed in the @GENE$ gene was not found to be a risk factor for @DISEASE$ or ulcerative colitis.",FA,MDR1,Crohn's disease,False
"In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis.","In this study, the G2677T/A polymorphism observed in the @GENE$ gene was not found to be a risk factor for Crohn's disease or @DISEASE$.",FA,MDR1,ulcerative colitis,False
"In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis.","In this study, the @DISEASE$ polymorphism observed in the MDR1 gene was not found to be a risk factor for @DISEASE$ or ulcerative colitis.",,G2677T/A,Crohn's disease,True
"In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis.","In this study, the @DISEASE$ polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or @DISEASE$.",,G2677T/A,ulcerative colitis,True
Regulation of hairy and enhancer of split homologue-1 (HES-1) by estradiol and all-trans retinoic acid affects proliferation of human breast cancer cells.,Regulation of @GENE$ (HES-1) by estradiol and all-trans retinoic acid affects proliferation of human @DISEASE$ cells.,FA,hairy and enhancer of split homologue-1,breast cancer,False
Estrogen-dependent downregulation of hairy and enhancer of split homolog-1 gene expression in breast cancer cells is mediated via a 3' distal element.,Estrogen-dependent downregulation of @GENE$ gene expression in @DISEASE$ cells is mediated via a 3' distal element.,FA,hairy and enhancer of split homolog-1,breast cancer,False
Regulation of hairy and enhancer of split homologue-1 (HES-1) by estradiol and all-trans retinoic acid affects proliferation of human breast cancer cells.,Regulation of hairy and enhancer of split homologue-1 (@GENE$) by estradiol and all-trans retinoic acid affects proliferation of human @DISEASE$ cells.,PA,HES-1,breast cancer,False
"Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers.","Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, @DISEASE$, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.",FA,rs13199524,HIV,True
Previous studies of the HIV-1 disease have shown that HLA and Chemokine receptor genetic variants influence disease progression and early viral load.,Previous studies of the @DISEASE$ have shown that HLA and @GENE$ genetic variants influence disease progression and early viral load.,PA,Chemokine receptor,HIV-1 disease,True
"Furthermore, we show that the HIV-DNA levels (reflecting the HIV reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).","Furthermore, we show that the HIV-DNA levels (reflecting the @DISEASE$ reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the @GENE$ gene).",PA,Syndecan 2,HIV,True
"Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers.","Moreover, protective alleles for four disease-associated SNPs in the MHC locus (@DISEASE$, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.",FA,rs2395029,HIV,False
Previous studies of the HIV-1 disease have shown that HLA and Chemokine receptor genetic variants influence disease progression and early viral load.,Previous studies of the @DISEASE$ have shown that @GENE$ and Chemokine receptor genetic variants influence disease progression and early viral load.,PA,HLA,HIV-1 disease,True
"Furthermore, we show that the HIV-DNA levels (reflecting the HIV reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).","Furthermore, we show that the HIV-DNA levels (reflecting the @DISEASE$ reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (@DISEASE$; within the Syndecan 2 gene).",FA,rs2575735,HIV,False
"Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers.","Moreover, protective alleles for four disease-associated SNPs in the @GENE$ locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.",FA,MHC,HIV,False
"Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers.","Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and @DISEASE$) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.",FA,rs3093662,HIV,False
Our data provide evidence that the MHC controls both HIV replication and HIV reservoir.,Our data provide evidence that the @GENE$ controls both HIV replication and @DISEASE$ reservoir.,FA,MHC,HIV,False
"Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers.","Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, @DISEASE$ and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.",FA,rs12198173,HIV,False
"Furthermore, we show that the HIV-DNA levels (reflecting the HIV reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).","Furthermore, we show that the HIV-DNA levels (reflecting the @DISEASE$ reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (@DISEASE$; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).",FA,rs6503919,HIV,False
The commonly deleted region of the 5q- syndrome extends between the genes SH3TC2 (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.,The commonly deleted region of the @DISEASE$ extends between the genes @GENE$ (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.,PA,SH3TC2,5q- syndrome,True
The commonly deleted region of the 5q- syndrome extends between the genes SH3TC2 (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.,The commonly deleted region of the @DISEASE$ extends between the genes SH3TC2 (proximal boundary) and @GENE$ (distal boundary) and measures 2.9 Mb.,PA,GLRA1,5q- syndrome,True
"Aberrant expression of chitinase 3-like 1 (CHI3L1), also known as YKL-40 or HC gp-39, is involved in the pathogenesis of inflammatory and allergic diseases.","Aberrant expression of chitinase 3-like 1 (CHI3L1), also known as YKL-40 or @GENE$, is involved in the pathogenesis of @DISEASE$.",PA,HC gp-39,inflammatory and allergic diseases,True
These results strongly suggest that the g.-247C/T polymorphism in the CHI3L1 promoter region is associated with the risk of atopy.,These results strongly suggest that the @DISEASE$ polymorphism in the CHI3L1 promoter region is associated with the risk of @DISEASE$.,PA,g.-247C/T,atopy,True
Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy.,Genetic variation in the promoter region of @GENE$ is associated with @DISEASE$.,PA,chitinase 3-like 1,atopy,True
"In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy.","In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the @DISEASE$ polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.",PA,IVS7+82C/T,atopy,True
"In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy.","In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (@DISEASE$; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.",PA,rs10399805,atopy,True
These results strongly suggest that the g.-247C/T polymorphism in the CHI3L1 promoter region is associated with the risk of atopy.,These results strongly suggest that the g.-247C/T polymorphism in the @GENE$ promoter region is associated with the risk of @DISEASE$.,PA,CHI3L1,atopy,True
The genetic contribution of CHI3L1 gene to atopic susceptibility was investigated using an integrated population genetic and molecular analysis.,The genetic contribution of @GENE$ gene to @DISEASE$ susceptibility was investigated using an integrated population genetic and molecular analysis.,PA,CHI3L1,atopic,True
Genetic variations in CHI3L1 were identified and genotyped in 295 unrelated patients with atopy and 180 control subjects.,Genetic variations in @GENE$ were identified and genotyped in 295 unrelated patients with @DISEASE$ and 180 control subjects.,PA,CHI3L1,atopy,True
"In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy.","In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of @GENE$ showed a significant association with @DISEASE$.",PA,CHI3L1,atopy,True
"In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy.","In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (@DISEASE$; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.",PA,rs2275353,atopy,True
"In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy.","In the case-control association analysis, the @DISEASE$ polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.",PA,g.-247C/T,atopy,True
"In humans, loss-of-function of the cilia-centrosomal protein CEP290/NPHP6 is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.","In humans, loss-of-function of the cilia-centrosomal protein @GENE$ is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in @DISEASE$ (LCA), a form of early-onset retinal dystrophy.",FA,CEP290/NPHP6,Leber congenital amaurosis,False
Hypomorphic CEP290/NPHP6 mutations result in anosmia caused by the selective loss of G proteins in cilia of olfactory sensory neurons.,Hypomorphic @GENE$/NPHP6 mutations result in @DISEASE$ caused by the selective loss of G proteins in cilia of olfactory sensory neurons.,FA,CEP290,anosmia,False
"In humans, loss-of-function of the cilia-centrosomal protein CEP290/NPHP6 is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.","In humans, loss-of-function of the cilia-centrosomal protein @GENE$ is associated with Joubert and @DISEASE$, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.",PA,CEP290/NPHP6,Meckel syndromes,True
"In humans, loss-of-function of the cilia-centrosomal protein CEP290/NPHP6 is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.","In humans, loss-of-function of the cilia-centrosomal protein @GENE$ is associated with @DISEASE$ and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.",PA,CEP290/NPHP6,Joubert,True
Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.,Association between donor @GENE$ and graft survival and the development of @DISEASE$ after lung transplantation.,SA,MBL promoter haplotype,BOS,True
"Compared with the epsilon3 homozygotes, neither the epsilon2 nor the epsilon4 carrier status was associated with hypertension (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).","Compared with the epsilon3 homozygotes, neither the epsilon2 nor the @DISEASE$ carrier status was associated with @DISEASE$ (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).",,epsilon4,hypertension,True
"Compared with the epsilon3 homozygotes, neither the epsilon2 nor the epsilon4 carrier status was associated with hypertension (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).","Compared with the epsilon3 homozygotes, neither the @DISEASE$ nor the epsilon4 carrier status was associated with @DISEASE$ (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).",,epsilon2,hypertension,True
"Apolipoprotein E (ApoE) polymorphism influences lipid metabolism, but its association with arterial hypertension is controversial.","@GENE$ (ApoE) polymorphism influences lipid metabolism, but its association with @DISEASE$ is controversial.",PA,Apolipoprotein E,arterial hypertension,True
This study provides epidemiologic evidence that the ApoE genotype is not associated with prevalent hypertension in old age.,This study provides epidemiologic evidence that the @GENE$ genotype is not associated with @DISEASE$ in old age.,,ApoE,prevalent hypertension,True
"Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to TAA and can serve as biomarkers for screening for this virulent disease.","Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase (@GENE$) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to @DISEASE$ and can serve as biomarkers for screening for this virulent disease.",PA,MMP,TAA,True
"Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to TAA and can serve as biomarkers for screening for this virulent disease.","Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) @GENE$ (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to @DISEASE$ and can serve as biomarkers for screening for this virulent disease.",PA,matrix metalloproteinase,TAA,True
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes @GENE$ (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",FA,LIGIV,papillary thyroid cancer,False
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, @DISEASE$, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",FA,PRO72ARG,papillary thyroid cancer,False
RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.,@GENE$ contribute to the development of @DISEASE$ susceptibility in Middle Eastern population.,PA,RAD52 polymorphisms,papillary thyroid cancer,True
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, @GENE$ UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",PA,Tp53,papillary thyroid cancer,True
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, @DISEASE$, ARG399GLN, ARG559GLN.",FA,ARG280HIS,papillary thyroid cancer,False
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and @DISEASE$, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",FA,GLN221GLU,papillary thyroid cancer,False
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene @GENE$ ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",PA,XRCC1,papillary thyroid cancer,True
"Of the 21 loci screened, RAD52 2259 and RAD52 GLN221GLU may be of importance to disease process and may be associated with papillary thyroid cancer risk in Saudi Arabian population.","Of the 21 loci screened, RAD52 2259 and @DISEASE$ may be of importance to disease process and may be associated with @DISEASE$ risk in Saudi Arabian population.",SA,RAD52 GLN221GLU,papillary thyroid cancer,True
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and @DISEASE$, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",FA,THR241MET,papillary thyroid cancer,False
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, @DISEASE$, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",FA,PRO231SER,papillary thyroid cancer,False
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, @DISEASE$, ARG559GLN.",FA,ARG399GLN,papillary thyroid cancer,False
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and @GENE$ ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",PA,XRCC7,papillary thyroid cancer,True
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, @DISEASE$.",FA,ARG559GLN,papillary thyroid cancer,False
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, @DISEASE$, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",FA,15455419A>G,papillary thyroid cancer,False
"RAD52 GLN221GLU genotypes CG and variants carrying G allele showed statistical significance and very high risk of developing thyroid cancer compared to wild type [CG vs CC; p<0.001, odds ratio (OR)=15.57, 95% confidence interval (CI)=6.56-36.98, CG+GG vs CC; p<0.001, OR=17.58, 95% CI=7.44-41.58].","@DISEASE$ genotypes CG and variants carrying G allele showed statistical significance and very high risk of developing @DISEASE$ compared to wild type [CG vs CC; p<0.001, odds ratio (OR)=15.57, 95% confidence interval (CI)=6.56-36.98, CG+GG vs CC; p<0.001, OR=17.58, 95% CI=7.44-41.58].",PA,RAD52 GLN221GLU,thyroid cancer,True
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, @GENE$ UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",PA,RAD51,papillary thyroid cancer,True
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes @GENE$ ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",PA,XRCC3,papillary thyroid cancer,True
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, @DISEASE$), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",FA,TRP46TER,papillary thyroid cancer,True
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (@DISEASE$, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",FA,LIGlV ASP62HIS,papillary thyroid cancer,True
"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.","Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), @GENE$ Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.",PA,XRCC4,papillary thyroid cancer,True
An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and intestinal cancer in GPx1 and GPx2 double knockout mice.,An anti-inflammatory and anticarcinogenic potential has been inferred from the development of @DISEASE$ and intestinal cancer in @GENE$ and GPx2 double knockout mice.,PA,GPx1,colitis,True
An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and intestinal cancer in GPx1 and GPx2 double knockout mice.,An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and @DISEASE$ in @GENE$ and GPx2 double knockout mice.,PA,GPx1,intestinal cancer,True
"Thus, GPx2 may prevent undue responses to inflammatory stimuli and, in consequence, inflammation-driven initiation of carcinogenesis.","Thus, @GENE$ may prevent undue responses to inflammatory stimuli and, in consequence, inflammation-driven initiation of @DISEASE$.",SA,GPx2,carcinogenesis,True
"In contrast, enhanced COX-2 expression is consistently associated with inflammation.","In contrast, enhanced @GENE$ expression is consistently associated with @DISEASE$.",PA,COX-2,inflammation,True
An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and intestinal cancer in GPx1 and GPx2 double knockout mice.,An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and @DISEASE$ in GPx1 and @GENE$ double knockout mice.,PA,GPx2,intestinal cancer,True
An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and intestinal cancer in GPx1 and GPx2 double knockout mice.,An anti-inflammatory and anticarcinogenic potential has been inferred from the development of @DISEASE$ and intestinal cancer in GPx1 and @GENE$ double knockout mice.,PA,GPx2,colitis,True
"For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A.","For the remaining markers, a susceptibility role was attributed also confirming that markers on @GENE$ gene, in particular G908R and L1007fsinsC, are involved with @DISEASE$ to the same extent as FcGIIIA G559T and TNF-alpha-G308A.",FA,CARD15,CD,True
"For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A.","For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular @DISEASE$ and L1007fsinsC, are involved with @DISEASE$ to the same extent as FcGIIIA G559T and TNF-alpha-G308A.",PA,G908R,CD,True
"For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A.","For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and @DISEASE$, are involved with @DISEASE$ to the same extent as FcGIIIA G559T and TNF-alpha-G308A.",PA,L1007fsinsC,CD,True
"For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A.","For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with @DISEASE$ to the same extent as FcGIIIA G559T and @DISEASE$.",PA,TNF-alpha-G308A,CD,True
The NF kappaB -94ATTG variants was found to be irrelevant for CD.,The @DISEASE$ variants was found to be irrelevant for @DISEASE$.,,NF kappaB -94ATTG,CD,True
"For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A.","For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with @DISEASE$ to the same extent as @DISEASE$ and TNF-alpha-G308A.",PA,FcGIIIA G559T,CD,True
"The C-allele of PKLR rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with type 2 diabetes in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.","The @DISEASE$ and the T-allele of NOS1AP rs7538490 are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.",PA,C-allele of PKLR rs3020781,type 2 diabetes,True
"Additionally, the PKLR and the NOS1AP genotypes were demonstrated not to have a major influence on diabetes-related quantitative metabolic phenotypes.","Additionally, the @GENE$ and the NOS1AP genotypes were demonstrated not to have a major influence on @DISEASE$.",,PKLR,diabetes-related quantitative metabolic phenotypes,True
"We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.","We failed to provide evidence of an association between PKLR rs3020781 and @GENE$ and type 2 diabetes, @DISEASE$, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.",FA,NOS1AP rs7538490,overweight,True
"The C-allele of PKLR rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with type 2 diabetes in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.","The C-allele of @GENE$ rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.",PA,PKLR,type 2 diabetes,False
"We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.","We failed to provide evidence of an association between @GENE$ and NOS1AP rs7538490 and @DISEASE$, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.",,PKLR rs3020781,type 2 diabetes,False
"No significant associations were observed for type 2 diabetes (rs3020781: pAF = 0.49, OR = 1.02 [0.96-1.10]; rs7538490: pAF = 0.84, OR = 0.99 [0.93-1.06]).","No significant associations were observed for @DISEASE$ (@DISEASE$: pAF = 0.49, OR = 1.02 [0.96-1.10]; rs7538490: pAF = 0.84, OR = 0.99 [0.93-1.06]).",,rs3020781,type 2 diabetes,False
"Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.","Lack of association between PKLR rs3020781 and @GENE$ and type 2 diabetes, overweight, @DISEASE$ and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.",FA,NOS1AP rs7538490,obesity,False
"Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.","Lack of association between PKLR rs3020781 and @GENE$ and type 2 diabetes, @DISEASE$, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.",FA,NOS1AP rs7538490,overweight,False
"We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.","We failed to provide evidence of an association between PKLR rs3020781 and @GENE$ and type 2 diabetes, overweight, @DISEASE$ or related quantitative metabolic phenotypes in large-scale studies of Danes.",FA,NOS1AP rs7538490,obesity,False
"Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.","Lack of association between @GENE$ and NOS1AP rs7538490 and @DISEASE$, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.",,PKLR rs3020781,type 2 diabetes,False
"The C-allele of PKLR rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with type 2 diabetes in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.","The C-allele of PKLR rs3020781 and the @DISEASE$ are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.",PA,T-allele of NOS1AP rs7538490,type 2 diabetes,True
"Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.","Lack of association between PKLR rs3020781 and @GENE$ and @DISEASE$, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.",,NOS1AP rs7538490,type 2 diabetes,True
"We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.","We failed to provide evidence of an association between PKLR rs3020781 and @GENE$ and @DISEASE$, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.",,NOS1AP rs7538490,type 2 diabetes,True
"Additionally, the PKLR and the NOS1AP genotypes were demonstrated not to have a major influence on diabetes-related quantitative metabolic phenotypes.","Additionally, the PKLR and the @GENE$ genotypes were demonstrated not to have a major influence on @DISEASE$.",,NOS1AP,diabetes-related quantitative metabolic phenotypes,True
"No significant associations were observed for type 2 diabetes (rs3020781: pAF = 0.49, OR = 1.02 [0.96-1.10]; rs7538490: pAF = 0.84, OR = 0.99 [0.93-1.06]).","No significant associations were observed for @DISEASE$ (rs3020781: pAF = 0.49, OR = 1.02 [0.96-1.10]; @DISEASE$: pAF = 0.84, OR = 0.99 [0.93-1.06]).",,rs7538490,type 2 diabetes,True
"The C-allele of PKLR rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with type 2 diabetes in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.","The C-allele of PKLR rs3020781 and the T-allele of @GENE$ rs7538490 are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.",PA,NOS1AP,type 2 diabetes,True
"We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.","We failed to provide evidence of an association between @GENE$ and NOS1AP rs7538490 and type 2 diabetes, overweight, @DISEASE$ or related quantitative metabolic phenotypes in large-scale studies of Danes.",FA,PKLR rs3020781,obesity,False
"Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.","Lack of association between @GENE$ and NOS1AP rs7538490 and type 2 diabetes, @DISEASE$, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.",FA,PKLR rs3020781,overweight,False
"Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.","Lack of association between @GENE$ and NOS1AP rs7538490 and type 2 diabetes, overweight, @DISEASE$ and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.",FA,PKLR rs3020781,obesity,True
"Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including oral leukoplakia and squamous cell carcinoma, relatively little research has compared the effects of various COX-2 inhibitors (celecoxib, NS-398, nimesulide and meloxicam).","Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including @DISEASE$ and squamous cell carcinoma, relatively little research has compared the effects of various @GENE$ inhibitors (celecoxib, NS-398, nimesulide and meloxicam).",PA,COX-2,oral leukoplakia,True
"Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including oral leukoplakia and squamous cell carcinoma, relatively little research has compared the effects of various COX-2 inhibitors (celecoxib, NS-398, nimesulide and meloxicam).","Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including oral leukoplakia and @DISEASE$, relatively little research has compared the effects of various @GENE$ inhibitors (celecoxib, NS-398, nimesulide and meloxicam).",PA,COX-2,squamous cell carcinoma,True
"Taken together, celecoxib is a good therapeutic candidate for treating OSCC through the suppression of cell proliferation and the induction of apoptosis in a COX-2 independent manner.","Taken together, celecoxib is a good therapeutic candidate for treating @DISEASE$ through the suppression of cell proliferation and the induction of apoptosis in a @GENE$ independent manner.",FA,COX-2,OSCC,True
From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene.,From the Cover: Whole-genome association study identifies @GENE$ as a @DISEASE$ susceptibility gene.,PA,STK39,hypertension,True
"Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (CD) as a consequence of a genome-wide association study of this disease in adults.","Recently an association was shown between the single nucleotide polymorphism (SNP), @DISEASE$, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (@DISEASE$) as a consequence of a genome-wide association study of this disease in adults.",PA,rs11209026,CD,True
"Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (CD) as a consequence of a genome-wide association study of this disease in adults.","Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (@GENE$) locus and @DISEASE$ (CD) as a consequence of a genome-wide association study of this disease in adults.",PA,IL23R,Crohn's disease,True
"Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (CD) as a consequence of a genome-wide association study of this disease in adults.","Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (@GENE$) locus and Crohn's disease (@DISEASE$) as a consequence of a genome-wide association study of this disease in adults.",FA,IL23R,CD,True
"Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (CD) as a consequence of a genome-wide association study of this disease in adults.","Recently an association was shown between the single nucleotide polymorphism (SNP), @DISEASE$, within the interleukin-23 receptor (IL23R) locus and @DISEASE$ (CD) as a consequence of a genome-wide association study of this disease in adults.",PA,rs11209026,Crohn's disease,True
"By using data from our ongoing genome-wide association study in our cohort of 142 pediatric CD patients and 281 matched controls, we investigated the association of the previously reported SNPs at the IL23R locus with the childhood form of this disease.","By using data from our ongoing genome-wide association study in our cohort of 142 pediatric @DISEASE$ patients and 281 matched controls, we investigated the association of the previously reported SNPs at the @GENE$ locus with the childhood form of this disease.",FA,IL23R,CD,True
"As such, variants in the IL23R gene confer a similar magnitude of risk of CD to children as for their adult counterparts.","As such, @GENE$ gene confer a similar magnitude of risk of @DISEASE$ to children as for their adult counterparts.",PA,variants in the IL23R,CD,True
"The OR of the IL23R variant in our pediatric study is highly comparable with that reported previously in a non-Jewish adult inflammatory bowel disease case-control cohort (OR, 0.26).","The OR of the @GENE$ in our pediatric study is highly comparable with that reported previously in a non-Jewish adult @DISEASE$ case-control cohort (OR, 0.26).",PA,IL23R variant,inflammatory bowel disease,True
Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease.,Association of variants of the @GENE$ gene with susceptibility to @DISEASE$.,PA,interleukin-23 receptor,pediatric Crohn's disease,True
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer.,Variations in the @GENE$ gene impact on survival of patients with advanced @DISEASE$.,PA,interleukin-1 receptor antagonist,colorectal cancer,True
The interleukin-1 receptor antagonist (IL-1RA) cytokine is thought to counteract tumor angiogenesis/metastasis.,The interleukin-1 receptor antagonist (@GENE$) cytokine is thought to counteract tumor angiogenesis/@DISEASE$.,SA,IL-1RA,metastasis,True
The interleukin-1 receptor antagonist (IL-1RA) cytokine is thought to counteract tumor angiogenesis/metastasis.,The interleukin-1 receptor antagonist (@GENE$) cytokine is thought to counteract @DISEASE$/metastasis.,SA,IL-1RA,tumor angiogenesis,True
A total of 180 patients with metastatic colorectal cancer were categorized as high IL-1RA producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers).,A total of 180 patients with @DISEASE$ were categorized as high IL-1RA producers if they were carriers of at least one of the rs4251961 T/T or @DISEASE$ genotypes (T/T carriers).,FA,rs579543 T/T,metastatic colorectal cancer,True
A total of 180 patients with metastatic colorectal cancer were categorized as high IL-1RA producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers).,A total of 180 patients with @DISEASE$ were categorized as high @GENE$ producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers).,PA,IL-1RA,metastatic colorectal cancer,True
A total of 180 patients with metastatic colorectal cancer were categorized as high IL-1RA producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers).,A total of 180 patients with @DISEASE$ were categorized as high IL-1RA producers if they were carriers of at least one of the @DISEASE$ or rs579543 T/T genotypes (T/T carriers).,FA,rs4251961 T/T,metastatic colorectal cancer,True
"Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.","Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (@DISEASE$) have been performed in a southern European population.",SA,VDR,MM,True
"Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.","Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in @DISEASE$ (BC) or malignant melanoma (MM) have been performed in a southern European population.",SA,VDR,sporadic breast cancer,False
"Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.","Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or @DISEASE$ (MM) have been performed in a southern European population.",SA,VDR,malignant melanoma,False
"The synonymous variant rs731236 (TaqI) appeared to be associated with protection from BC (OR = 0.80, 95%CI = 0.64-0.99; p = 0.047).","The synonymous variant @DISEASE$ (TaqI) appeared to be associated with protection from @DISEASE$ (OR = 0.80, 95%CI = 0.64-0.99; p = 0.047).",SA,rs731236,BC,False
"Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.","Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (@DISEASE$) or malignant melanoma (MM) have been performed in a southern European population.",SA,VDR,BC,False
"Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.","Vitamin D receptor (@GENE$) genotypes may influence @DISEASE$ risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.",PA,VDR,cancer,False
"In summary, we observed associations between SNPs in the VDR gene and BC risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with MM.","In summary, we observed associations between @GENE$ gene and BC risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with @DISEASE$.",SA,SNPs in the VDR,MM,False
"An association with the minor allele A of the non-synonymous SNP rs2228570 (rs10735810, FokI, Met1Thr) was observed for BC, with an estimated odds ratio (OR) of 1.26 (95% CI = 1.02-1.57; p = 0.036).","An association with the minor allele A of the non-synonymous SNP @DISEASE$ (rs10735810, FokI, Met1Thr) was observed for @DISEASE$, with an estimated odds ratio (OR) of 1.26 (95% CI = 1.02-1.57; p = 0.036).",FA,rs2228570,BC,False
"An association with the minor allele A of the non-synonymous SNP rs2228570 (rs10735810, FokI, Met1Thr) was observed for BC, with an estimated odds ratio (OR) of 1.26 (95% CI = 1.02-1.57; p = 0.036).","An association with the minor allele A of the non-synonymous SNP rs2228570 (@DISEASE$, FokI, Met1Thr) was observed for @DISEASE$, with an estimated odds ratio (OR) of 1.26 (95% CI = 1.02-1.57; p = 0.036).",PA,rs10735810,BC,True
"In summary, we observed associations between SNPs in the VDR gene and BC risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with MM.","In summary, we observed associations between @GENE$ gene and @DISEASE$ risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with MM.",PA,SNPs in the VDR,BC,True
"A common SNP upstream of the INSIG2 gene, rs7566605 (g.-10,1025G>C, Chr2:118,552,255, NT_022135.15), was reported to be associated with obesity (Body Mass Index, [BMI]) in a genome-wide association scan using the Framingham Heart Study but has not been reproduced in other cohorts.","A common SNP upstream of the @GENE$ gene, rs7566605 (g.-10,1025G>C, Chr2:118,552,255, NT_022135.15), was reported to be associated with @DISEASE$ (Body Mass Index, [BMI]) in a genome-wide association scan using the Framingham Heart Study but has not been reproduced in other cohorts.",PA,INSIG2,obesity,True
"A common SNP upstream of the INSIG2 gene, rs7566605 (g.-10,1025G>C, Chr2:118,552,255, NT_022135.15), was reported to be associated with obesity (Body Mass Index, [BMI]) in a genome-wide association scan using the Framingham Heart Study but has not been reproduced in other cohorts.","A common SNP upstream of the INSIG2 gene, @DISEASE$ (g.-10,1025G>C, Chr2:118,552,255, NT_022135.15), was reported to be associated with @DISEASE$ (Body Mass Index, [BMI]) in a genome-wide association scan using the Framingham Heart Study but has not been reproduced in other cohorts.",FA,rs7566605,obesity,False
This supports and extends the original finding that there is an association between measures of obesity and INSIG2 rs7566605 and further implicates this polymorphism in fat regulation.,This supports and extends the original finding that there is an association between measures of @DISEASE$ and @GENE$ and further implicates this polymorphism in fat regulation.,PA,INSIG2 rs7566605,obesity,True
Our results show that the INSIG2 rs7566605 polymorphism underlies variation in subcutaneous adiposity in young adult women and suppresses the positive effects of resistance training on men.,Our results show that the @GENE$ polymorphism underlies variation in subcutaneous @DISEASE$ in young adult women and suppresses the positive effects of resistance training on men.,PA,INSIG2 rs7566605,adiposity,True
"Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of AD.","Our previous study demonstrated that expression of @GENE$ mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of @DISEASE$.",PA,HCNPpp,AD,True
"Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of AD.","Our previous study demonstrated that expression of @GENE$ mRNA was decreased in the hippocampi of autopsied brains of @DISEASE$ (AD) patients, indicating the association of HCNP with the pathogenesis of AD.",PA,HCNPpp,Alzheimer's disease,True
"To clarify the involvement of gene variations in the promoter region of the gene encoding HCNPpp in this mRNA reduction, we analyzed DNA polymorphisms or mutations within this gene promoter region in AD patients by direct sequencing.","To clarify the involvement of gene variations in the promoter region of the gene encoding @GENE$ in this mRNA reduction, we analyzed DNA polymorphisms or mutations within this gene promoter region in @DISEASE$ patients by direct sequencing.",FA,HCNPpp,AD,False
"Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of AD.","Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of @GENE$ with the pathogenesis of @DISEASE$.",PA,HCNP,AD,True
"Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of AD.","Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of @DISEASE$ (AD) patients, indicating the association of @GENE$ with the pathogenesis of AD.",PA,HCNP,Alzheimer's disease,True
The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity.,The @DISEASE$ polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with @DISEASE$ and obesity.,PA,K121Q,insulin resistance,True
The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity.,The @DISEASE$ polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and @DISEASE$.,PA,K121Q,obesity,True
Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.,Association of a genetic polymorphism in @GENE$ with @DISEASE$ and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.,FA,ectonucleotide pyrophosphatase/phosphodiesterase 1,hepatitis C virus infection,True
"In contrast, the rs7566605 genotype was not associated with hepatitis C viremia or with the HCV core antigen level.","In contrast, the @DISEASE$ genotype was not associated with @DISEASE$ viremia or with the HCV core antigen level.",FA,rs7566605,hepatitis C,True
The K121Q variant of ENPP1 may be associated with hepatitis C viremia and core antigen levels in HCV carriers.,The @DISEASE$ variant of ENPP1 may be associated with @DISEASE$ viremia and core antigen levels in HCV carriers.,FA,K121Q,hepatitis C,True
The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity.,The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (@GENE$ gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and @DISEASE$.,FA,ENPP)-1,obesity,True
The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity.,The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (@GENE$ gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with @DISEASE$ and obesity.,FA,ENPP)-1,insulin resistance,True
This study examined whether the K121Q polymorphism in ENPP1 or the rs7566605 genotype is associated with the clinical course of HCV infection.,This study examined whether the @DISEASE$ polymorphism in ENPP1 or the rs7566605 genotype is associated with the clinical course of @DISEASE$.,PA,K121Q,HCV infection,True
This study examined whether the K121Q polymorphism in ENPP1 or the rs7566605 genotype is associated with the clinical course of HCV infection.,This study examined whether the K121Q polymorphism in ENPP1 or the @DISEASE$ genotype is associated with the clinical course of @DISEASE$.,PA,rs7566605,HCV infection,True
This study examined whether the K121Q polymorphism in ENPP1 or the rs7566605 genotype is associated with the clinical course of HCV infection.,This study examined whether the K121Q polymorphism in @GENE$ or the rs7566605 genotype is associated with the clinical course of @DISEASE$.,PA,ENPP1,HCV infection,True
The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity.,The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the @DISEASE$ genotype located near insulin-induced gene 2 have been shown to be associated with @DISEASE$ and obesity.,PA,rs7566605,insulin resistance,True
The K121Q variant of ENPP1 may be associated with hepatitis C viremia and core antigen levels in HCV carriers.,The K121Q variant of @GENE$ may be associated with @DISEASE$ viremia and core antigen levels in HCV carriers.,PA,ENPP1,hepatitis C,True
The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity.,The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the @DISEASE$ genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and @DISEASE$.,PA,rs7566605,obesity,True
"Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with Mycobacterium leprae antigens and found that -819T carriers produced lower levels of IL-10 when compared with non-carriers.","Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with @DISEASE$ and found that -819T carriers produced lower levels of @GENE$ when compared with non-carriers.",PA,IL-10,Mycobacterium leprae antigens,True
"Taken together, these data suggest that low levels of IL-10 during the disease outcome can drive patients to a chronic and unprotective response that culminates with leprosy.","Taken together, these data suggest that low levels of @GENE$ during the disease outcome can drive patients to a chronic and unprotective response that culminates with @DISEASE$.",SA,IL-10,leprosy,True
"Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility.","Genetic, epidemiological and biological analysis of @GENE$ suggests a definitive role for -819C/T in @DISEASE$ susceptibility.",PA,interleukin-10 promoter single-nucleotide polymorphisms,leprosy,True
"Here, we combined a case-control study (374 patients and 380 controls), with meta-analysis (5 studies; 2702 individuals) and biological study to test the epidemiological and physiological relevance of the interleukin-10 (IL-10) genetic markers in leprosy.","Here, we combined a case-control study (374 patients and 380 controls), with meta-analysis (5 studies; 2702 individuals) and biological study to test the epidemiological and physiological relevance of the interleukin-10 (@GENE$) genetic markers in @DISEASE$.",PA,IL-10,leprosy,True
"Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility.","Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for @DISEASE$ in @DISEASE$ susceptibility.",PA,-819C/T,leprosy,False
Haplotypes combining promoter single-nucleotide polymorphisms also implicated a haplotype carrying the -819T allele in leprosy susceptibility (odds ratio (OR)=1.40; P=0.01).,Haplotypes combining promoter single-nucleotide polymorphisms also implicated a haplotype carrying the @DISEASE$ allele in @DISEASE$ susceptibility (odds ratio (OR)=1.40; P=0.01).,PA,-819T,leprosy,False
"Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with Mycobacterium leprae antigens and found that -819T carriers produced lower levels of IL-10 when compared with non-carriers.","Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with @DISEASE$ and found that @DISEASE$ carriers produced lower levels of IL-10 when compared with non-carriers.",FA,-819T,Mycobacterium leprae antigens,False
We observed that the -819T allele is associated with leprosy susceptibility either in the case-control or in the meta-analysis studies.,We observed that the @DISEASE$ allele is associated with @DISEASE$ susceptibility either in the case-control or in the meta-analysis studies.,PA,-819T,leprosy,False
The implicated LOXL1 polymorphisms have not been associated with primary open-angle glaucoma (POAG).,The implicated @GENE$ have not been associated with primary open-angle glaucoma (@DISEASE$).,FA,LOXL1 polymorphisms,POAG,False
"Individual LOXL1 SNPs, rs1048661, rs3825942, and rs2165241, were not associated with POAG in the Chinese population.","Individual LOXL1 SNPs, rs1048661, @DISEASE$, and rs2165241, were not associated with @DISEASE$ in the Chinese population.",,rs3825942,POAG,False
"The lysyl oxidase-like protein 1 (LOXL1) gene is strongly associated with exfoliation glaucoma, which is very rare in the Chinese population.","The lysyl oxidase-like protein 1 (@GENE$) gene is strongly associated with @DISEASE$, which is very rare in the Chinese population.",PA,LOXL1,exfoliation glaucoma,False
The low frequencies of the at-risk alleles at rs1048661 and rs2165241 may be one of the factors that led to the low prevalence of exfoliation syndrome in the general populations of the Chinese.,The low frequencies of the at-risk alleles at @DISEASE$ and rs2165241 may be one of the factors that led to the low prevalence of @DISEASE$ in the general populations of the Chinese.,SA,rs1048661,exfoliation syndrome,True
"Individual LOXL1 SNPs, rs1048661, rs3825942, and rs2165241, were not associated with POAG in the Chinese population.","Individual LOXL1 SNPs, rs1048661, rs3825942, and @DISEASE$, were not associated with @DISEASE$ in the Chinese population.",,rs2165241,POAG,True
The low frequencies of the at-risk alleles at rs1048661 and rs2165241 may be one of the factors that led to the low prevalence of exfoliation syndrome in the general populations of the Chinese.,The low frequencies of the at-risk alleles at rs1048661 and @DISEASE$ may be one of the factors that led to the low prevalence of @DISEASE$ in the general populations of the Chinese.,SA,rs2165241,exfoliation syndrome,True
"Individual LOXL1 SNPs, rs1048661, rs3825942, and rs2165241, were not associated with POAG in the Chinese population.","Individual @GENE$ SNPs, rs1048661, rs3825942, and rs2165241, were not associated with @DISEASE$ in the Chinese population.",FA,LOXL1,POAG,False
"Individual LOXL1 SNPs, rs1048661, rs3825942, and rs2165241, were not associated with POAG in the Chinese population.","Individual LOXL1 SNPs, @DISEASE$, rs3825942, and rs2165241, were not associated with @DISEASE$ in the Chinese population.",,rs1048661,POAG,True
Compound heterozygosity for the C677T and A1298C mutations of the MTHFR gene in a case of hyperhomocysteinemia with recurrent deep thrombosis at young age.,Compound heterozygosity for the C677T and @GENE$ gene in a case of @DISEASE$ with recurrent deep thrombosis at young age.,PA,A1298C mutations of the MTHFR,hyperhomocysteinemia,True
Compound heterozygosity for the C677T and A1298C mutations of the MTHFR gene in a case of hyperhomocysteinemia with recurrent deep thrombosis at young age.,Compound heterozygosity for the @DISEASE$ and A1298C mutations of the MTHFR gene in a case of @DISEASE$ with recurrent deep thrombosis at young age.,FA,C677T,hyperhomocysteinemia,False
"In CD patients, TLR-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms.","In @DISEASE$ patients, TLR-induced GM-CSF secretion was impaired by both @GENE$-dependent and -independent mechanisms.",FA,NOD2,CD,True
The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of CD and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a NOD2-dependent disease risk factor.,The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of @DISEASE$ and is consistent with the hypothesis that impaired @GENE$ secretion in part constitutes a NOD2-dependent disease risk factor.,FA,GM-CSF,CD,True
"Based on NOD2 SNP analyses, 41 CD patients and 12 healthy controls were studied.","Based on @GENE$ analyses, 41 @DISEASE$ patients and 12 healthy controls were studied.",FA,NOD2 SNP,CD,True
Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.,@GENE$-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in @DISEASE$ by nucleotide oligomerization domain 2-dependent and -independent pathways.,PA,Toll-like receptor,Crohn's disease,True
Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.,Toll-like receptor-induced @GENE$ secretion is impaired in @DISEASE$ by nucleotide oligomerization domain 2-dependent and -independent pathways.,PA,granulocyte-macrophage colony-stimulating factor,Crohn's disease,True
"Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in CD patients.","Moreover, TNF-alpha production was induced by a @GENE$-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in @DISEASE$ patients.",FA,TLR,CD,True
CD patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.,@DISEASE$ patients have impaired @GENE$ secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.,FA,GM-CSF,CD,True
CD patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.,@DISEASE$ patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of @GENE$ secretion.,FA,TNF-alpha,CD,True
"Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, nucleotide oligomerization domain 2) are associated with Crohn's disease (CD).","Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (@GENE$, nucleotide oligomerization domain 2) are associated with @DISEASE$ (CD).",PA,NOD2,Crohn's disease,True
"Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, nucleotide oligomerization domain 2) are associated with Crohn's disease (CD).","Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (@GENE$, nucleotide oligomerization domain 2) are associated with Crohn's disease (@DISEASE$).",PA,NOD2,CD,True
"CD patients with NOD2 mutations were able to secrete TNF-alpha, but not GM-CSF, upon stimulation with NOD2 and TLR-7 ligands.","@DISEASE$ patients with NOD2 mutations were able to secrete TNF-alpha, but not @GENE$, upon stimulation with NOD2 and TLR-7 ligands.",FA,GM-CSF,CD,True
The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of CD and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a NOD2-dependent disease risk factor.,The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of @DISEASE$ and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a @GENE$-dependent disease risk factor.,PA,NOD2,CD,True
CD patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.,@DISEASE$ patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired @GENE$-dependent down-regulation of TNF-alpha secretion.,PA,NOD2,CD,True
"Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, nucleotide oligomerization domain 2) are associated with Crohn's disease (CD).","Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, @GENE$) are associated with Crohn's disease (@DISEASE$).",PA,nucleotide oligomerization domain 2,CD,True
"Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, nucleotide oligomerization domain 2) are associated with Crohn's disease (CD).","Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, @GENE$) are associated with @DISEASE$ (CD).",PA,nucleotide oligomerization domain 2,Crohn's disease,True
"In CD patients, TLR-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms.","In @DISEASE$ patients, TLR-induced @GENE$ secretion was impaired by both NOD2-dependent and -independent mechanisms.",FA,GM-CSF,CD,True
Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.,Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in @DISEASE$ by @GENE$-dependent and -independent pathways.,FA,nucleotide oligomerization domain 2,Crohn's disease,True
"Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in CD patients.","Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the @GENE$ ligand, muramyl dipeptide, was impaired significantly in @DISEASE$ patients.",PA,NOD2,CD,True
"In CD patients, TLR-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms.","In @DISEASE$ patients, @GENE$-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms.",PA,TLR,CD,True
The IL-23 pathway plays a pivotal role in the development of chronic mucosal inflammation seen in the inflammatory bowel diseases.,The @GENE$ pathway plays a pivotal role in the development of @DISEASE$ seen in the inflammatory bowel diseases.,PA,IL-23,chronic mucosal inflammation,True
IL23R haplotypes provide a large population attributable risk for Crohn's disease.,@GENE$ provide a large population attributable risk for @DISEASE$.,SA,IL23R haplotypes,Crohn's disease,True
Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (CD) risk in general and of the IL23R R381Q variant in particular.,Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to @DISEASE$ (CD) risk in general and of the @DISEASE$ variant in particular.,PA,IL23R R381Q,Crohn's disease,False
"These observations suggest that IL23R makes a substantial contribution to CD susceptibility, larger than that estimated from the population frequency of the R381Q variant.","These observations suggest that IL23R makes a substantial contribution to @DISEASE$ susceptibility, larger than that estimated from the population frequency of the @DISEASE$ variant.",SA,R381Q,CD,False
Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (CD) risk in general and of the IL23R R381Q variant in particular.,Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (@DISEASE$) risk in general and of the @DISEASE$ variant in particular.,PA,IL23R R381Q,CD,False
The IL-23 pathway plays a pivotal role in the development of chronic mucosal inflammation seen in the inflammatory bowel diseases.,The @GENE$ pathway plays a pivotal role in the development of chronic mucosal inflammation seen in the @DISEASE$.,PA,IL-23,inflammatory bowel diseases,False
Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (CD) risk in general and of the IL23R R381Q variant in particular.,Multiple studies have now established the contribution of the interleukin 23 receptor gene (@GENE$) to Crohn's disease (@DISEASE$) risk in general and of the IL23R R381Q variant in particular.,PA,IL23R,CD,False
"These observations suggest that IL23R makes a substantial contribution to CD susceptibility, larger than that estimated from the population frequency of the R381Q variant.","These observations suggest that @GENE$ makes a substantial contribution to @DISEASE$ susceptibility, larger than that estimated from the population frequency of the R381Q variant.",SA,IL23R,CD,False
Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (CD) risk in general and of the IL23R R381Q variant in particular.,Multiple studies have now established the contribution of the interleukin 23 receptor gene (@GENE$) to @DISEASE$ (CD) risk in general and of the IL23R R381Q variant in particular.,PA,IL23R,Crohn's disease,False
"In all, 763 CD subjects and 254 controls were genotyped for single nucleotide polymorphisms in the IL23R gene using Illumina and ABI methods.","In all, 763 @DISEASE$ subjects and 254 controls were genotyped for single nucleotide polymorphisms in the @GENE$ gene using Illumina and ABI methods.",FA,IL23R,CD,False
Identification and replication of three novel myopia common susceptibility gene loci on chromosome 3q26 using linkage and linkage disequilibrium mapping.,Identification and replication of three novel @DISEASE$ common susceptibility gene loci on chromosome @GENE$ using linkage and linkage disequilibrium mapping.,PA,3q26,myopia,False
"In a family, we observed c.+119A > T in the 3'-UTR associated with ASD type II.","In a family, we observed @DISEASE$ associated with @DISEASE$.",PA,c.+119A > T in the 3'-UTR,ASD type II,True
Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.,Elevation of @GENE$ expression in @DISEASE$ with Gsalpha protein mutation.,PA,growth hormone-releasing hormone receptor messenger ribonucleic acid,growth hormone-secreting pituitary adenoma,True
"The expression of GHRH receptor (GHRHR) is regulated by GHRH, both of which are known to be expressed in human GH-secreting pituitary adenoma cells.","The expression of @GENE$ (GHRHR) is regulated by GHRH, both of which are known to be expressed in human @DISEASE$ cells.",PA,GHRH receptor,GH-secreting pituitary adenoma,True
"These results suggest that gsp mutations up-regulate GHRHR mRNA expression in GH-secreting pituitary adenoma cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of GHRH signaling.","These results suggest that gsp mutations up-regulate GHRHR mRNA expression in @DISEASE$ cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of @GENE$ signaling.",PA,GHRH,GH-secreting pituitary adenoma,True
"The expression of GHRH receptor (GHRHR) is regulated by GHRH, both of which are known to be expressed in human GH-secreting pituitary adenoma cells.","The expression of GHRH receptor (GHRHR) is regulated by @GENE$, both of which are known to be expressed in human @DISEASE$ cells.",PA,GHRH,GH-secreting pituitary adenoma,True
"These results suggest that gsp mutations up-regulate GHRHR mRNA expression in GH-secreting pituitary adenoma cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of GHRH signaling.","These results suggest that gsp mutations up-regulate GHRHR mRNA expression in @DISEASE$ cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their @GENE$ expression probably because of their saturation of GHRH signaling.",PA,GHRHR mRNA,GH-secreting pituitary adenoma,True
Cdc6 play crucial roles in DNA replication and carcinogenesis.,@GENE$ play crucial roles in DNA replication and @DISEASE$.,PA,Cdc6,carcinogenesis,True
Our data provide the first evidence that the Cdc6 G1321A polymorphism is associated with decreased risk of cancer.,Our data provide the first evidence that the @GENE$ polymorphism is associated with decreased risk of @DISEASE$.,PA,Cdc6 G1321A,cancer,True
"To assess clinical significance, 93 breast cancer lesions were evaluated for expression of VEGF and VEGFR-1 by immunohistochemistry.","To assess clinical significance, 93 @DISEASE$ lesions were evaluated for expression of @GENE$ and VEGFR-1 by immunohistochemistry.",PA,VEGF,breast cancer,True
"To assess clinical significance, 93 breast cancer lesions were evaluated for expression of VEGF and VEGFR-1 by immunohistochemistry.","To assess clinical significance, 93 @DISEASE$ lesions were evaluated for expression of VEGF and @GENE$ by immunohistochemistry.",PA,VEGFR-1,breast cancer,True
Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage.,Expression of VEGFR-1 (@GENE$) in @DISEASE$ is associated with VEGF expression and with node-negative tumour stage.,PA,Flt-1,breast cancer,True
Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage.,Expression of VEGFR-1 (Flt-1) in @DISEASE$ is associated with @GENE$ expression and with node-negative tumour stage.,PA,VEGF,breast cancer,True
VEGF was expressed in 60% and VEGFR-1 in 39% of breast cancer specimens.,@GENE$ was expressed in 60% and VEGFR-1 in 39% of @DISEASE$ specimens.,PA,VEGF,breast cancer,True
VEGF was expressed in 60% and VEGFR-1 in 39% of breast cancer specimens.,VEGF was expressed in 60% and @GENE$ in 39% of @DISEASE$ specimens.,PA,VEGFR-1,breast cancer,True
Vascular endothelial growth factor (VEGF) promotes breast cancer progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells.,Vascular endothelial growth factor (@GENE$) promotes @DISEASE$ progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells.,PA,VEGF,breast cancer,True
Vascular endothelial growth factor (VEGF) promotes breast cancer progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells.,Vascular endothelial growth factor (VEGF) promotes @DISEASE$ progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (@GENE$) expressed on tumour cells.,PA,Flt-1,breast cancer,True
"We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin.","We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and @DISEASE$) of the IL2RA in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.",FA,rs11594656,type 1 diabetes,True
Our objective was to determine whether variants in the IL2RA gene are associated with type 1 diabetes in the Japanese population.,Our objective was to determine whether variants in the @GENE$ gene are associated with @DISEASE$ in the Japanese population.,PA,IL2RA,type 1 diabetes,True
"We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin.","We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the @GENE$ in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.",PA,IL2RA,type 1 diabetes,True
The present data confirm the type 1 diabetes association with IL2RA and provide evidence that the different contributions of the IL2RA in the susceptibility to acute-onset and other forms of type 1 diabetes in the Japanese population.,The present data confirm the type 1 diabetes association with IL2RA and provide evidence that the different contributions of the @GENE$ in the susceptibility to acute-onset and other forms of @DISEASE$ in the Japanese population.,PA,IL2RA,type 1 diabetes,True
"We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin.","We genotyped the four single-nucleotide polymorphisms (rs706778, @DISEASE$, ss52580101, and rs11594656) of the IL2RA in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.",FA,rs3118470,type 1 diabetes,True
"We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin.","We genotyped the four single-nucleotide polymorphisms (@DISEASE$, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.",FA,rs706778,type 1 diabetes,True
"We found evidence of association with acute-onset, but not slow-onset and fulminant, type 1 diabetes for two of the four single-nucleotide polymorphisms genotyped (rs706778 and rs3118470).","We found evidence of association with acute-onset, but not slow-onset and fulminant, @DISEASE$ for two of the four single-nucleotide polymorphisms genotyped (rs706778 and @DISEASE$).",PA,rs3118470,type 1 diabetes,True
"We found evidence of association with acute-onset, but not slow-onset and fulminant, type 1 diabetes for two of the four single-nucleotide polymorphisms genotyped (rs706778 and rs3118470).","We found evidence of association with acute-onset, but not slow-onset and fulminant, @DISEASE$ for two of the four single-nucleotide polymorphisms genotyped (@DISEASE$ and rs3118470).",PA,rs706778,type 1 diabetes,True
"We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin.","We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, @DISEASE$, and rs11594656) of the IL2RA in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.",FA,ss52580101,type 1 diabetes,True
TGFBIp/betaig-h3 protein is an extracellular matrix molecule initially cloned from human adenocarcinoma cells treated with TGF-beta.,@GENE$ protein is an extracellular matrix molecule initially cloned from human @DISEASE$ cells treated with TGF-beta.,PA,TGFBIp/betaig-h3,adenocarcinoma,True
Polymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infection.,Polymorphisms in the regulatory region of the @GENE$ gene influence the susceptibility for HIV-1 @DISEASE$.,PA,Cyclophilin A,infection,False
Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A (CypA) and susceptibility to both HIV-1 infection and disease progression.,Previous studies have demonstrated an association between polymorphisms in the regulatory regions of @GENE$ (CypA) and susceptibility to both HIV-1 @DISEASE$ and disease progression.,PA,Cyclophilin A,infection,False
Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A (CypA) and susceptibility to both HIV-1 infection and disease progression.,Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A (@GENE$) and susceptibility to both HIV-1 @DISEASE$ and disease progression.,PA,CypA,infection,False
"The results obtained in this study suggest that the A1650G polymorphism in the regulatory region of the CypA gene may be associated with protection from HIV-1 infection, while the 1604G allele may have a weak association with the clinical course of infection in DU.","The results obtained in this study suggest that the A1650G polymorphism in the regulatory region of the @GENE$ gene may be associated with protection from HIV-1 @DISEASE$, while the 1604G allele may have a weak association with the clinical course of infection in DU.",FA,CypA,infection,False
Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or cervical squamous cell carcinoma compared to His1104Asp or His1104His genotypes.,Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or @DISEASE$ compared to @DISEASE$ or His1104His genotypes.,FA,His1104Asp,cervical squamous cell carcinoma,False
No association of XRCC3 Thr241Met or XPD Lys751Gln and cervical carcinoma was found.,No association of XRCC3 Thr241Met or @DISEASE$ and @DISEASE$ was found.,,XPD Lys751Gln,cervical carcinoma,False
"DNA repair gene polymorphisms, such as those of XRCC3 and xeroderma pigmentosum, complementation group D and G (XPD, XPG), contribute to carcinogenesis.","DNA repair gene polymorphisms, such as those of @GENE$ and xeroderma pigmentosum, complementation group D and G (XPD, XPG), contribute to @DISEASE$.",PA,XRCC3,carcinogenesis,False
"Similarly, XPD Asn312Asn (AA) reduced the risk of cervical or cervical squamous cell carcinoma.","Similarly, @DISEASE$ (AA) reduced the risk of cervical or @DISEASE$.",PA,XPD Asn312Asn,cervical squamous cell carcinoma,True
No association of XRCC3 Thr241Met or XPD Lys751Gln and cervical carcinoma was found.,No association of @DISEASE$ or XPD Lys751Gln and @DISEASE$ was found.,,XRCC3 Thr241Met,cervical carcinoma,True
Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or cervical squamous cell carcinoma compared to His1104Asp or His1104His genotypes.,Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or @DISEASE$ compared to His1104Asp or @DISEASE$ genotypes.,FA,His1104His,cervical squamous cell carcinoma,False
Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or cervical squamous cell carcinoma compared to His1104Asp or His1104His genotypes.,Women carrying homozygous @DISEASE$ genotypes had a significantly decreased risk of cervical or @DISEASE$ compared to His1104Asp or His1104His genotypes.,PA,Asp1104Asp,cervical squamous cell carcinoma,True
"Much of this data has been correlative, until recently with the development of polymerase gamma deficient mice which accumulate high levels of mtDNA mutations and show a premature aging phenotype, that a more causative role has been proposed.","Much of this data has been correlative, until recently with the development of @GENE$ deficient mice which accumulate high levels of mtDNA mutations and show a @DISEASE$ phenotype, that a more causative role has been proposed.",PA,polymerase gamma,premature aging,True
A recent study demonstrated the association of TNFSF4 haplotypes located in the upstream region with risk for or protection from systemic lupus erythematosus (SLE).,A recent study demonstrated the association of @GENE$ located in the upstream region with risk for or protection from systemic lupus erythematosus (@DISEASE$).,PA,TNFSF4 haplotypes,SLE,True
A recent study demonstrated the association of TNFSF4 haplotypes located in the upstream region with risk for or protection from systemic lupus erythematosus (SLE).,A recent study demonstrated the association of @GENE$ located in the upstream region with risk for or protection from @DISEASE$ (SLE).,PA,TNFSF4 haplotypes,systemic lupus erythematosus,True
The association of TNFSF4 with SLE was replicated in all the sets except Spain.,The association of @GENE$ with @DISEASE$ was replicated in all the sets except Spain.,PA,TNFSF4,SLE,True
Replication of the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosus.,Replication of the TNFSF4 (@GENE$) promoter region association with @DISEASE$.,PA,OX40L,systemic lupus erythematosus,True
This first replication study confirms the association of genetic variation in the upstream region of TNFSF4 with susceptibility to SLE.,This first replication study confirms the association of genetic variation in the upstream region of @GENE$ with susceptibility to @DISEASE$.,PA,TNFSF4,SLE,True
These results suggest that NPTN may be involved in genetic susceptibility to schizophrenia.,These results suggest that @GENE$ may be involved in genetic susceptibility to @DISEASE$.,SA,NPTN,schizophrenia,True
"The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.","The haplotypes constructed from the three SNPs (rs3840846, @DISEASE$ and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in @DISEASE$.",PA,rs3826047,schizophrenia,True
"The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.","The haplotypes constructed from the three SNPs (@DISEASE$, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in @DISEASE$.",PA,rs3840846,schizophrenia,True
"The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.","The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and @DISEASE$, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in @DISEASE$.",PA,rs3743500,schizophrenia,True
"The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.","The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of @GENE$ showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in @DISEASE$.",PA,NPTN,schizophrenia,True
Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor.,@DISEASE$ is associated with decreased expression of mucosal @GENE$.,PA,interleukin 22 receptor,Chronic rhinosinusitis with nasal polyps,True
IL-22R1 mRNA was expressed in 100% of the controls and CRSsNP.,@GENE$ mRNA was expressed in 100% of the controls and @DISEASE$.,PA,IL-22R1,CRSsNP,True
"However, IL-22R1 was only expressed in 55% of patients with recalcitrant CRSwNP.","However, @GENE$ was only expressed in 55% of patients with @DISEASE$.",PA,IL-22R1,recalcitrant CRSwNP,True
Further research is needed to determine the potential of IL-22R1 as a therapeutic target in CRSwNP.,Further research is needed to determine the potential of @GENE$ as a therapeutic target in @DISEASE$.,SA,IL-22R1,CRSwNP,True
"Additionally, levels of IL22R1 were significantly lower in recalcitrant CRSwNP compared to controls and CRSsNP.","Additionally, levels of @GENE$ were significantly lower in recalcitrant CRSwNP compared to controls and @DISEASE$.",FA,IL22R1,CRSsNP,False
"Additionally, levels of IL22R1 were significantly lower in recalcitrant CRSwNP compared to controls and CRSsNP.","Additionally, levels of @GENE$ were significantly lower in @DISEASE$ compared to controls and CRSsNP.",PA,IL22R1,recalcitrant CRSwNP,True
Failure of medical and surgical therapy in CRSwNP is associated with significantly decreased expression of IL-22R1.,Failure of medical and surgical therapy in @DISEASE$ is associated with significantly decreased expression of @GENE$.,SA,IL-22R1,CRSwNP,True
Fetuin-A is a calcification inhibitor and correlates negatively with increased vascular stiffness in dialysis patients.,@GENE$ is a calcification inhibitor and correlates negatively with increased @DISEASE$ in dialysis patients.,PA,Fetuin-A,vascular stiffness,True
"Male fetuin-A SerSer carriers demonstrate particularly high aortic stiffness, possibly implying a status of increased cardiovascular risk.","Male @GENE$ SerSer carriers demonstrate particularly high @DISEASE$, possibly implying a status of increased cardiovascular risk.",PA,fetuin-A,aortic stiffness,True
The fetuin-A polymorphism (Thr256Ser) is associated with reduced fetuin levels and accelerated vascular calcification in dialysis patients.,The @GENE$ polymorphism (Thr256Ser) is associated with reduced fetuin levels and accelerated @DISEASE$ in dialysis patients.,PA,fetuin-A,vascular calcification,True
EGFR gene expression in pancreatic adenocarcinoma cells significantly surpassed that in normal pancreatic cells.,@GENE$ gene expression in @DISEASE$ cells significantly surpassed that in normal pancreatic cells.,PA,EGFR,pancreatic adenocarcinoma,True
Role of epidermal growth factor gene in the development of pancreatic cancer and efficiency of inhibitors of this gene in the treatment of pancreatic carcinoma.,Role of @GENE$ gene in the development of pancreatic cancer and efficiency of inhibitors of this gene in the treatment of @DISEASE$.,PA,epidermal growth factor,pancreatic carcinoma,True
"On the other hand, AA genome and A allele polymorphism in the EGF gene nucleotide pair G-A 61 is a significant risk factor for pancreatic cancer.","On the other hand, AA genome and A allele polymorphism in the @GENE$ gene nucleotide pair G-A 61 is a significant risk factor for @DISEASE$.",PA,EGF,pancreatic cancer,True
